Last edition
News about "JB Chemicals Delivers Strong Q3 FY26 Results with "
JB Chemicals Delivers Strong Q3 FY26 Results with Double-Digit Growth
JB Chemicals and Pharmaceuticals Ltd (JB Pharma) reported a strong financial performance for the third quarter of FY26, with consolidated revenue rising to INR 1,065 crore, an increase of around 11 percent compared to the same quarter last year.
JB Chemicals Delivers Strong Q3 FY26 Results With | 20/01/2026 | By Darshana | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members